INDRAMEDCO

Indraprastha Medical Corporation Limited

Tertiary-care hospital services under Indraprastha Apollo franchise

Healthcare›Healthcare›Healthcare Services›Hospital

apollohospitals.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹320.05
Market cap
2,934 Cr
Stock P/E
15.6
P/B
3.96
Dividend yield
1.4%
ROE (FY26)
24.8%
ROCE (FY26)
34.0%
Operating margin (FY26)
15.1%
OCF / EBITDA (FY26)
62.7%
OCF / EBITDA (3Y)
74.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Indraprastha Medical Corporation provides hospital healthcare services in New Delhi under the Indraprastha Apollo Hospitals name, from its base at Sarita Vihar.

Company snapshot

17thBy market cap

Ranked among 24 companies in Hospital.

What we see

Positives
  • ✓Interest coverage of 37.1x — earnings comfortably cover interest obligations.
1 more signal from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales317 Cr306 Cr315 Cr348 Cr350 Cr325 Cr334 Cr365 Cr381 Cr372 Cr365 Cr406 Cr
Operating expenses (approx.)267 Cr259 Cr266 Cr281 Cr286 Cr273 Cr272 Cr292 Cr310 Cr310 Cr304 Cr326 Cr
EBITDA50 Cr47 Cr48 Cr67 Cr64 Cr52 Cr61 Cr73 Cr71 Cr62 Cr61 Cr80 Cr
OPM %15.9%15.4%15.4%19.3%18.2%16.1%18.4%20.0%18.7%16.7%16.6%19.7%
Other income4 Cr4 Cr5 Cr5 Cr6 Cr5 Cr6 Cr7 Cr7 Cr7 Cr7 Cr8 Cr
Interest0.85 Cr0.87 Cr2 Cr2 Cr2 Cr2 Cr1 Cr2 Cr2 Cr1 Cr1 Cr2 Cr
Depreciation10 Cr10 Cr10 Cr11 Cr11 Cr11 Cr11 Cr10 Cr11 Cr11 Cr11 Cr12 Cr
Profit before tax44 Cr41 Cr42 Cr60 Cr57 Cr45 Cr55 Cr68 Cr66 Cr56 Cr55 Cr75 Cr
Tax %24.7%27.6%25.0%24.9%25.5%26.3%25.8%24.7%25.4%27.3%24.2%25.4%
Net profit33 Cr29 Cr31 Cr45 Cr42 Cr33 Cr41 Cr51 Cr49 Cr41 Cr42 Cr56 Cr
EPS (₹)₹3.58₹3.21₹3.40₹4.88₹4.63₹3.58₹4.47₹5.61₹5.40₹4.47₹4.55₹6.09

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales766 Cr748 Cr788 Cr831 Cr613 Cr888 Cr1,099 Cr1,245 Cr1,356 Cr1,483 CrSign in free for the trailing twelve months
Operating expenses (approx.)688 Cr676 Cr707 Cr744 Cr573 Cr774 Cr948 Cr1,051 Cr1,112 Cr1,216 CrSign in free for the trailing twelve months
EBITDA78 Cr72 Cr81 Cr86 Cr40 Cr114 Cr151 Cr193 Cr244 Cr267 CrSign in free for the trailing twelve months
OPM %10.1%9.6%10.2%10.4%6.6%12.9%13.7%15.5%18.0%18.0%Sign in free for the trailing twelve months
Other income2 Cr2 Cr0.47 Cr0.69 Cr0.68 Cr3 Cr10 Cr17 Cr23 Cr29 CrSign in free for the trailing twelve months
Interest8 Cr9 Cr7 Cr6 Cr3 Cr3 Cr4 Cr4 Cr6 Cr6 CrSign in free for the trailing twelve months
Depreciation31 Cr31 Cr30 Cr33 Cr33 Cr35 Cr39 Cr40 Cr44 Cr44 CrSign in free for the trailing twelve months
Profit before tax41 Cr34 Cr45 Cr48 Cr4 Cr79 Cr117 Cr166 Cr216 Cr246 CrSign in free for the trailing twelve months
Tax %35.7%37.9%36.3%9.5%45.7%25.9%26.5%25.4%25.6%25.4%Sign in free for the trailing twelve months
Net profit26 Cr21 Cr28 Cr44 Cr2 Cr59 Cr86 Cr124 Cr161 Cr184 CrSign in free for the trailing twelve months
EPS (₹)₹2.86₹2.30₹3.10₹4.76₹0.25₹6.39₹9.40₹13.52₹17.56₹20.03Sign in free for the trailing twelve months
Dividend payout %————0.0%0.4%26.5%22.2%25.3%22.3%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital92 Cr92 Cr92 Cr92 Cr92 Cr92 Cr92 Cr92 Cr92 Cr92 Cr
Reserves139 Cr141 Cr152 Cr176 Cr181 Cr234 Cr288 Cr386 Cr505 Cr649 Cr
Borrowings65 Cr60 Cr15 Cr4 Cr——————
Other liabilities196 Cr144 Cr163 Cr177 Cr159 Cr136 Cr176 Cr245 Cr255 Cr251 Cr
Total liabilities492 Cr436 Cr422 Cr449 Cr432 Cr462 Cr555 Cr723 Cr852 Cr991 Cr
Fixed assets (net)294 Cr293 Cr280 Cr301 Cr280 Cr275 Cr274 Cr346 Cr327 Cr364 Cr
CWIP——1 Cr0 Cr3 Cr0 Cr3 Cr0.47 Cr33 Cr3 Cr
Investments——0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Loans & advances——0.32 Cr0.25 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories10 Cr9 Cr8 Cr12 Cr9 Cr10 Cr8 Cr8 Cr7 Cr8 Cr
Trade receivables98 Cr87 Cr76 Cr79 Cr67 Cr43 Cr68 Cr58 Cr75 Cr112 Cr
Cash & bank3 Cr3 Cr17 Cr20 Cr25 Cr42 Cr52 Cr62 Cr61 Cr5 Cr
Other assets87 Cr44 Cr40 Cr36 Cr48 Cr91 Cr150 Cr249 Cr348 Cr499 Cr
Total assets492 Cr436 Cr422 Cr449 Cr432 Cr462 Cr555 Cr723 Cr852 Cr991 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity28 Cr48 Cr75 Cr86 Cr28 Cr71 Cr144 Cr200 Cr157 Cr167 Cr
Cash from investing-22 Cr-30 Cr-17 Cr-40 Cr-20 Cr-51 Cr-108 Cr-158 Cr-111 Cr-178 Cr
Cash from financing-5 Cr-17 Cr-44 Cr-43 Cr-3 Cr-3 Cr-26 Cr-32 Cr-46 Cr-46 Cr
Net cash flow0.60 Cr0.58 Cr14 Cr4 Cr5 Cr17 Cr11 Cr9 Cr-0.12 Cr-57 Cr
Free cash flow (OCF − Capex)5 Cr17 Cr58 Cr46 Cr7 Cr42 Cr100 Cr131 Cr120 Cr108 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %16.5%14.7%19.9%19.9%2.8%25.3%32.0%35.6%37.3%34.0%
ROE %11.4%9.1%11.6%16.3%0.9%18.0%22.7%25.9%27.0%24.8%
Debtor days47433535401823172028
Inventory days5242129282116131111
Days payable48186228250293161185235194182
Cash conversion cycle4-120-172-186-225-122-146-205-162-143
OCF / EBITDA %36.6%66.3%93.1%100.1%69.3%62.4%95.9%103.5%64.2%62.7%
OCF / EBITDA % (3 years)——65.7%87.5%91.4%77.0%79.8%90.7%85.2%74.4%
Debt / equity0.280.260.060.01——————
Current ratio0.870.961.091.011.221.681.721.862.412.46
Net debt / EBITDA0.80—-0.02-0.19-0.62-0.37-0.35-0.32-0.25-0.02